Company Overview and News

 
RIU GoodOilConference examines State’s Canning Basin

2018-09-14 proactiveinvestors.com.au
RIU GoodOilConference Perth welcomed a series of leading professionals to the stage on its day, playing host to Buru Energy Ltd (ASX:BRU) executive chairman Eric Streitberg and Geological Survey of Western Australia geophysicist Alex Zhan who both spoke about the state’s Canning Basin.
BRNGF BRU

 
RIU GoodOilConference Perth to open with financing perspective from Westpac’s Mark Beeley

2018-09-12 proactiveinvestors.com.au
RIU GoodOilConference Perth will deliver more good oil for the industry during day two of the event, as Westpac Banking Corp’s (ASX:WBC) (NZE:WBC) (FRA:WBC) (NYSE:WBK) Westpac Institutional Bank energy and resources director Mark Beeley opens with a talk on Financing Considerations.
FAR TEG SXA SSLZY SGC MEL LCK BAS ICN ROG BRNGF MUR ICNOF COPJF AGYYF FARYF COE WBC CUEYF NWE STRXD STO WEBNF STRXF ELXPF WBK CUE CUEYY AJQ WBC OIEXF EXR KEY OEX BRU

 
RIU GoodOilConference Perth opens with financing perspective from Westpac’s Mark Beeley

2018-09-12 proactiveinvestors.com.au
RIU GoodOilConference Perth will deliver more good oil for the industry during day two of the event, as Westpac Banking Corp’s (ASX:WBC) (NZE:WBC) (FRA:WBC) (NYSE:WBK) Westpac Institutional Bank energy and resources director Mark Beeley opens with a talk on Financing Considerations.
FAR TEG SXA SSLZY SGC MEL LCK BAS ICN ROG BRNGF MUR ICNOF COPJF AGYYF FARYF COE WBC CUEYF NWE STRXD STO WEBNF STRXF ELXPF WBK CUE CUEYY AJQ WBC OIEXF EXR KEY OEX BRU

 
RIU GoodOilConference Perth and WA Petroleum Day to put oil and gas players centre stage

2018-09-07 proactiveinvestors.com.au
The RIU GoodOilConference in Perth next week will focus on the current state of the oil and gas industry, and the explorers and producers operating in Australia.
FAR TEG HZN SXA SGC SRNLY LIO TAOIF BAS ICN BEPTF MUR COMRF CPTLY COPJF AGYYF NWE STRXD STRXF CUE ADX CTP EXR HZR BRU PCL CVN TAO SUR MEL LCK HZNFF ROG LIOEF BRNGF ICNOF FARYF COE CUEYF COI ADXRF ELXPF BCHEY CVONF CUEYY BPT AJQ RLE OIEXF CVX KEY OEX

 
Buru Energy gets good flow rates from Ungani Far West, begins Ungani 4 sidetrack operations, Roc Oil farm-in completed

2018-09-04 proactiveinvestors.com.au
Buru Energy Ltd (ASX:BRU) has started sidetrack operations at its Ungani 4 well and production testing at its Ungani Far West 1 well as oil output increases at the Ungani operations.
BRNGF BRU

 
Buru Energy production at Ungani oilfield nears 1 million barrels, Trafigura lifts another 51,962 barrels

2018-08-20 proactiveinvestors.com.au
Buru Energy Limited (ASX:BRU) is nearing production of one million barrels of oil at its Ungani operations in Western Australia with Trafigura lifting further oil from CGL storage Tank 10 at Wyndham on August 16, 2018.
BRNGF BRU

 
Buru Energy set to reach one million barrels of cumulative production at Ungani oilfield

2018-08-10 proactiveinvestors.com.au
Buru Energy Limited (ASX:BRU) has revealed total cumulative production of 959,000 barrels as of 7 August from the Ungani oilfield, with the production of the millionth barrel expected later in August.
BRNGF BRU

 
Buru Energy moving steadily towards 1,800 barrels of oil per day at Ungani Oilfield

2018-07-23 proactiveinvestors.com.au
Buru Energy Limited’s (ASX:BRU) production optimisation activities at the Ungani Oilfield are continuing with well operations at Ungani 4 and Ungani 5 close to completion.
BRNGF BRU

 
Buru Energy accelerating exploration efforts following Roc Oil transactions

2018-05-22 proactiveinvestors.com.au
Buru Energy (ASX:BRU) executive chairman Eric Streitberg speaks to Proactive Investors about the Australia-focused oil and gas company's recent deal with Roc Oil (ASX:ROC) to sell half of its 100% ownership in the Ungani Oilfield for $64 million, and enter a Joint Venture on three of its most advanced exploration permits for a carry of $20 million. Buru Energy retains operatorship.
BRNGF BRU

 
Buru Energy to receive $84 million through sale and farm-in deal

2018-05-22 proactiveinvestors.com.au
Buru Energy Ltd (ASX:BRU) has entered into two transactions valued at $84 million with Roc Oil in relation to its Canning Basin oil production and exploration assets in Western Australia.
BRNGF BRU

 
Buru Energy to ramp up oil production from Ungani oilfield

2018-05-13 proactiveinvestors.com.au
Buru Energy Ltd (ASX:BRU) is producing from the Ungani 1 and Ungani 2 wells at a combined rate of up to 1,700 barrels of oil per day (bopd) on low pump rate settings as expected.
BRNGF BRU

 
Buru Energy has oil flowing again at Ungani project in Western Australia

2018-05-07 proactiveinvestors.com.au
Buru Energy Limited (ASX:BRU) has brought the Ungani 1 and 2 wells at the Ungani Oilfield Project in Western Australia back into production with strong results.
BRNGF BRU

 
Buru Energy set to restart oil production following access road reopening

2018-05-01 proactiveinvestors.com.au
Buru Energy Ltd (ASX:BRU) has sent 2,541 barrels of crude inventory to the storage tank at Wyndham after fully reopening the access road to its wholly-owned Ungani Oilfield in Western Australia.
BRNGF BRU

 
Buru Energy regains some access to Ungani Oil Field

2018-04-17 proactiveinvestors.com.au
Buru Energy Ltd (ASX:BRU) is able to use the Ungani access road with light vehicles as water levels have generally receded below the roadbed level.
BRNGF BRU

Related Articles

ALIM: Alimera Sciences Analysis and Research Report

2018-10-01 - Asif

Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...

DMPI: DelMar Pharmaceuticals Analysis and Research Report

2018-09-25 - Asif

Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

Silicon Investor Message Boards

This table lists all message boards related to ASX:BRU / BURU ENERGY LIMITED on message board site Silicon Investor.

College Football: Nits, Gators, Bruins, Vols - Whoever! College Football: Nits, Gators, Bruins, Vols - Whoever! College Football: Nits, Gators, Bruins, Vols - Whoever! BRUSH CREEK MINING AND DEVELOPMENT (BCMD) NEWS BRUSH CREEK MINING AND DEVELOPMENT (BCMD) NEWS BRUSH CREEK MINING AND DEVELOPMENT (BCMD) NEWS
New Brunswick Scientific Co., Inc. (NBSC) New Brunswick Scientific Co., Inc. (NBSC) New Brunswick Scientific Co., Inc. (NBSC) Brush Engineered Materials Brush Engineered Materials Brush Engineered Materials
BDAL - Bruker Daltronics BDAL - Bruker Daltronics BDAL - Bruker Daltronics BBC - Bergen Brunswick Company BBC - Bergen Brunswick Company BBC - Bergen Brunswick Company
Watching Bruce Lee Watching Bruce Lee Watching Bruce Lee Brueggeru0027s Bagel Bakery bought by QDIN. Buy QDIN now?!! Brueggeru0027s Bagel Bakery bought by QDIN. Buy QDIN now?!! Brueggeru0027s Bagel Bakery bought by QDIN. Buy QDIN now?!!
Brunswick Technologies - BTIC Brunswick Technologies - BTIC Brunswick Technologies - BTIC Why is Bruce L such an annoying poster? Why is Bruce L such an annoying poster? Why is Bruce L such an annoying poster?